Clinical Trial Update: DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies [Phase 4]

View source ↗

Summary

A Phase 4 pilot-series trial update evaluating haemodynamic effects of semaglutide and tirzepatide in cardiovascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• MOUNJARO (tirzepatide)
• OZEMPIC (semaglutide)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Cardiovascular Diseases | Phase 4 | Status: NOT_YET_RECRUITING